Preferred Label : hemophilia b, nos;

Details


Main resources

You can consult :


https://www.cochrane.org/fr/CD014544/CF_quels-sont-les-benefices-et-les-risques-des-nouveaux-traitements-par-facteurs-non-coagulants-pour-la
2024
United Kingdom
review of literature
french abstract
risk factors
blood coagulation factors
hemophilia B
bloodletting
coagulants
Treatment Benefit
Feeding
Breeding
Risk Factor
Coagulation Factor
hemophilia b, nos
persons
risks and benefits
risk factor
F9 wt Allele
Feeding Ability
Prevention Study
Hemophilia B
What Month is it
disease
Raw
coagulation factor, nos
Hemorrhage
Preventive Intervention
risk assessment
bleeding precautions
hemorrhage
People
New Lesion Identification
Newar Language
preventive treatment, nos

---
https://anpgm.fr/media/documents/anpgm_135-deficits_constitutionnels_rares_en_facteurs_de_coagulation.pdf
2018
France
guideline
hemophilia b, nos
coagulation factor, nos
Hemophilia B
blood coagulation disorder, nos
genes
coagulants
hemophilia B
von willebrand diseases
von willebrand factor
Rare disease
Coagulation factors
rare diseases
Diseases
coagulants

---
https://anpgm.fr/media/documents/ANPGM_080-v2-Hemophilie.pdf
2016
France
guideline
Hemophilia B
hemophilia B
genes
hemophilia b, nos

---
Nous contacter.
18/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.